Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

          - [Release No. 34-74486; File No. SR-FINRA-2014-030]

                    On June 27, 2014, the Financial Industry Regulatory Authority, Inc. (“FINRA”) filed with the Securities and Exchange Commission (“Commission”), pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (“Act”) [1]                                          and Rule 19b-4 thereunder,[2]                                          a proposed rule change to adopt rules relating to quotation requirements for over-the-counter (“OTC”) equity securities and to delete the rules relating to the OTC Bulletin Board Service (“OTCBB”) and thus cease its operation. The proposed rule change was published for comment in the                     **Federal Register**                     on July 15, 2014.[3]                                          On August 8, 2014, FINRA consented to extending the time period for the Commission to either approve or disapprove the proposed rule change, or to institute proceedings to determine whether to approve or disapprove the proposed rule change, to October 10, 2014. The Commission received one comment letter on the proposed rule change.[4] 

                    On October 7, 2014, the Commission instituted proceedings [5]                                          to determine whether to approve or disapprove the proposed rule change under Section 19(b)(2)(B) of the Act.[6]                                          The Commission thereafter received three comment letters in response to the Order Instituting Proceedings.[7]                                          On January 9, 2015, the Commission extended the time period for Commission action to March 12, 2015.[8] 

On March 3, 2015, FINRA withdrew the proposed rule change (SR-FINRA-2014-030).

                        For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.[9] 

Brent J. Fields,

Secretary.

# Footnotes

1.                             15 U.S.C. 78s(b)(1).                    
        Back to Citation      

2.                             17 CFR 240.19b-4.                    
        Back to Citation      

3.                                                     *See*                         Securities Exchange Act Release No. 72575 (July 9, 2014), 79 FR 41339 (“Notice”).                    
        Back to Citation      

4.                                                     *See*                         Letter from Daniel Zinn, General Counsel, OTC Markets Group Inc., dated August 5, 2014.                    
        Back to Citation      

5.                                                     *See*                         Securities Exchange Act Release No. 73313, 79 FR 61677 (October 14, 2014) (“Order Instituting Proceedings”).                    
        Back to Citation      

6.                             15 U.S.C. 78s(b)(2)(B).                    
        Back to Citation      

7.                                                     *See*                         Letter from Dr. Lee Jackson, PAHCII, dated October 8, 2014; Letter from Barry Scadden, Vice President, ATS Trade Support and Operations, Global OTC, dated October 10, 2014; and Letter from Michael R. Trocchio, Sidley Austin LLP, on behalf of OTC Markets Group Inc., dated November 4, 2014.                    
        Back to Citation      

8.                                                     *See*                         Securities Exchange Act Release No. 74021, 80 FR 2142 (January 15, 2015).                    
        Back to Citation      

9.                                 17 CFR 200.30-3(a)(12).                        
        Back to Citation      

[FR Doc. 2015-06090 Filed 3-16-15; 8:45 am]

 BILLING CODE 8011-01-P